Advent International
Healthcare
Bulk drugs maker to pop out ‘benchmark returns' pill for Morgan Stanley
ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ......
People
Advent International executive resigns to join sovereign wealth fund
A top Advent International executive has resigned to join a United Arab Emirates-based sovereign wealth fund, as the latter builds ......
Healthcare
Morgan Stanley-backed bulk-drugs maker ZCL Chemicals attracts four bidders
Bulk-drugs manufacturer ZCL Chemicals Ltd, which had initiated talks last year to provide Morgan Stanley Private Equity Asia with an ......
Finance
Flashback 2020: How three PE trends gained momentum in virus-scarred year
Faced with new realities in the aftermath of the coronavirus outbreak, private equity firms challenged established dealmaking trends and adjusted ......
Finance
Flashback 2020: PE firms clock big exits but Indian VC gets most bang for the buck
Private equity and venture capital exit deals in India fell for the fourth consecutive year in 2020 as the coronavirus ......
Manufacturing
Advent, Temasek score neat returns in partial exit from Crompton Greaves Consumer
US private equity firm Advent International and Singapore state investor Temasek Holdings have scored neat returns from yet another partial ......
Manufacturing
Manjushree Technopack strikes second takeover deal under Advent
Less than 10 months after it bought a majority stake in an Amritsar-based firm, plastic packaging material maker Manjushree Technopack ......
Healthcare
Carlyle weighs possible bid for south India bulk-drugs firm
Private equity firm The Carlyle Group is evaluating a Hyderabad-based bulk-drugs maker as part of its plan to build an ......
Healthcare
Advent International poised to take control of another drugmaker
Private equity firm Advent International is set to strike its second deal within a year for a controlling stake in ......
Finance
Fund Scan: After hectic 2019, can Advent ride out the virus storm in India?
In private equity, as in any other investment, getting the timing right is often a matter of luck. American PE ......